26 Stratos
Table 2: Atrial Fibrillation Demographics at Enrollment
Characteristic | Group 1 | Group 2 | Group 3 | |||||
Rate Control |
|
|
|
|
|
|
| |
Medication, |
|
|
|
|
|
|
| |
Reasons for |
|
|
|
|
|
|
| |
Discontinuation |
| N=17 |
| N=20 |
| N=12 |
| |
Ineffective | 10 | (58.8%) | 13 | (65.0%) | 9 | (75.0%) | 0.558 | |
Not tolerated | 8 (47.1%) | 7 (35.0%) | 3 | (25.0%) | 0.760 | |||
Other | 1 | (5.9%) | 2 (10.0%) | 0 (0.0%) | 0.800 | |||
Rhythm Control |
|
|
|
|
|
|
| |
Medication, |
|
|
|
|
|
|
| |
Reasons for |
|
|
|
|
|
|
| |
Discontinuation |
| N=22 |
| N=25 |
| N=13 |
| |
Ineffective | 17 | (77.3%) | 20 | (80.0%) | 8 | (61.5%) | 0.759 | |
Not tolerated | 6 (27.3%) | 7 (28.0%) | 6 | (46.2%) | 0.530 | |||
Other | 1 | (4.5%) | 1 | (4.0%) | 2 | (15.4%) | 0.430 | |
Cardioversion |
|
|
|
|
|
|
| |
History |
| N=42 |
| N=49 |
| N=25 |
| |
Successful prior |
|
|
| 0.760 | ||||
electrical | 13 | (31.0%) | 16 | (32.7%) | 10 (40.0%) | |||
cardioversion |
|
|
|
|
|
|
| |
Transthoracic | 13 (100.0%) | 15 | (93.8%) | 10 | (100.0%) | 0.808 | ||
Transvenous | ||||||||
0 | (0.0%) | 1 | (6.3%) | 0 (0.0%) |
| |||
Unsuccessful prior | 0.680 | |||||||
15 | (35.7%) | 14 | (28.6%) | 7 | (28.0%) | |||
electrical | ||||||||
|
|
|
|
|
|
| ||
cardioversion |
|
|
|
|
|
|
| |
Transthoracic | 15 (100.0%) | 14 | (93.3%) | 7 (100.0%) | 0.741 | |||
Transvenous | ||||||||
0 | (0.0%) | 2 (13.3%) | 0 (0.0%) |
| ||||
No electrical | 0.936 | |||||||
17 | (40.5%) | 20 | (40.8%) | 9 | (36.0%) | |||
cardioversion |
|
|
|
|
|
|
| |
attempted |
|
|
|
|
|
|
| |
Successful prior | 5 (11.9%) | 3 | (6.1%) | 3 | (12.0%) | 0.547 | ||
pharmacological |
|
|
|
|
|
|
| |
cardioversion |
|
|
|
|
|
| 0.678 | |
Unsuccessful prior | 8 (19.0%) | 11 | (22.4%) | 7 | (28.0%) | |||
pharmacological |
|
|
|
|
|
|
| |
cardioversion | 23 | (54.8%) | 29 | (59.2%) | 15 (60.0%) | 0.915 | ||
No pharmacological | ||||||||
cardioversion |
|
|
|
|
|
|
| |
attempted |
|
|
|
|
|
|
| |